Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase. - Institut Pasteur Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Year : 2011

Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.

Abstract

We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'- and 5'-modified thymidine analogues including α- and β-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-α-thymidine analogue being the most active one (K(i)=0.17μM). This compound was capable of inhibiting mycobacteria growth at a concentration of 25μg/mL.

Dates and versions

pasteur-00645423 , version 1 (28-11-2011)

Identifiers

Cite

Sara van Poecke, Hélène Munier-Lehmann, Olivier Helynck, Matheus Froeyen, Serge van Calenbergh. Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.. Bioorganic and Medicinal Chemistry, 2011, 19, epub ahead of print. ⟨10.1016/j.bmc.2011.10.021⟩. ⟨pasteur-00645423⟩

Collections

PASTEUR CNRS
60 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More